Literature DB >> 31100207

Stanniocalcin-1 and -2 effects on glucose and lipid metabolism in white adipose tissue from fed and fasted rats.

Elaine Sarapio1,1, Samir K De Souza1,1, Jorge F A Model1,1, Marcia Trapp1,1, Roselis S M Da Silva1,1.   

Abstract

Stanniocalcin-1 and -2 belong to a family of molecules that exhibit both paracrine and autocrine effects in mammalian cells. Human stanniocalcin-1 (hSTC-1) is expressed in a wide range of tissues, including white adipose tissue. In fed rats, hSTC-1 increases carbon flux from glucose to lipids in retroperitoneal white adipose tissue. Human stanniocalcin-2 (hSTC-2) is expressed in almost all tissues and regulates various biological processes. The aim of this work was to study the action of hSTC-1 and hSTC-2 in the lipid and glucose metabolism of epididymal white adipose tissue (eWAT) in rats in different nutritional states. This study shows for the first time an opposite effect of hSTC-1 and hSTC-2 on glyceride-glycerol generation from glucose in eWAT of fed rats. hSTC-1 stimulated the storage of triacylglycerol in eWAT in the postprandial period, increasing glucose uptake and glyceride-glycerol generation from 14C-glucose. hSTC-2 decreased triacylglycerol synthesis, reducing glyceride-glycerol generation from 14C-glucose, direct phosphorylation of glycerol, and fatty acid synthesis from 14C-glucose in eWAT of fed rats. However, both hormones increased glucose uptake in fed and fasting states. These findings provide evidence for a direct role of hSTC-1 and hSTC-2 in the regulation of lipid and glucose metabolism in eWAT of rats.

Entities:  

Keywords:  fasting; fed; glucose; glycerol; glycérol; jeûne; metabolism; métabolisme; stanniocalcin 1; stanniocalcin 2; stanniocalcine 1; stanniocalcine 2; tissu adipeux blanc; white adipose tissue; état alimenté

Mesh:

Substances:

Year:  2019        PMID: 31100207     DOI: 10.1139/cjpp-2019-0023

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas.

Authors:  Yuchao Liu; Shihua Yin
Journal:  J Oncol       Date:  2020-09-24       Impact factor: 4.375

2.  LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.

Authors:  Jinxue Zhang; Yuan Zhang; Shiyang Cheng; Yang Mu; Yongming Liu; Xin Yi; Dongxu Jiang; Yong Ding; Ran Zhuang
Journal:  World J Surg Oncol       Date:  2020-06-20       Impact factor: 2.754

3.  Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer.

Authors:  Masuma Khatun; Elina Urpilainen; Anne Ahtikoski; Riikka K Arffman; Annukka Pasanen; Ulla Puistola; Juha S Tapanainen; Leif C Andersson; Ralf Butzow; Mikko Loukovaara; Terhi T Piltonen
Journal:  Pathol Oncol Res       Date:  2021-09-28       Impact factor: 3.201

Review 4.  Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.

Authors:  Shuo Qie; Nianli Sang
Journal:  J Exp Clin Cancer Res       Date:  2022-05-02

5.  Deimination Protein Profiles in Alligator mississippiensis Reveal Plasma and Extracellular Vesicle-Specific Signatures Relating to Immunity, Metabolic Function, and Gene Regulation.

Authors:  Michael F Criscitiello; Igor Kraev; Lene H Petersen; Sigrun Lange
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 6.  New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2.

Authors:  Aditya D Joshi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-31       Impact factor: 5.555

7.  Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma.

Authors:  Yu Pan; Geng-Yuan Hu; Shi Jiang; Shun-Jie Xia; Hendi Maher; Zhong-Jie Lin; Qi-Jiang Mao; Jie Zhao; Liu-Xin Cai; Ying-Hua Xu; Jun-Jie Xu; Xiu-Jun Cai
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.